Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 38 for:    Recruiting Studies | Multiple Myeloma | Spain | ( Map: Spain )

A Study of Melflufen in Combination With Dexamethasone in Relapsed Refractory Multiple Myeloma Patients (HORIZON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02963493
Recruitment Status : Recruiting
First Posted : November 15, 2016
Last Update Posted : September 2, 2019
Sponsor:
Collaborator:
Precision for Medicine, Oncology and Rare Disease
Information provided by (Responsible Party):
Oncopeptides AB

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : November 2021